vs
BayCom Corp（BCML）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
BayCom Corp的季度营收约是TriSalus Life Sciences, Inc.的2.0倍（$25.9M vs $13.2M），BayCom Corp净利率更高（26.5% vs -73.9%，领先100.3%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 9.4%），BayCom Corp自由现金流更多（$30.1M vs $-2.5M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs 2.9%）
BayCom Corp是总部位于美国的银行控股公司，旗下拥有海湾商业银行，主要服务北加州地区的中小微企业与零售客户，提供商业贷款、存款产品、个人银行、财富管理等多元金融服务，深耕本土社区金融市场。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
BCML vs TLSI — 直观对比
营收规模更大
BCML
是对方的2.0倍
$13.2M
营收增速更快
TLSI
高出50.4%
9.4%
净利率更高
BCML
高出100.3%
-73.9%
自由现金流更多
BCML
多$32.6M
$-2.5M
两年增速更快
TLSI
近两年复合增速
2.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.9M | $13.2M |
| 净利润 | $6.9M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | 36.6% | -24.8% |
| 净利率 | 26.5% | -73.9% |
| 营收同比 | 9.4% | 59.8% |
| 净利润同比 | 12.1% | 3.5% |
| 每股收益（稀释后） | $0.63 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCMLTLSI
| Q4 25 | $25.9M | $13.2M | ||
| Q3 25 | $25.7M | $11.6M | ||
| Q2 25 | $24.7M | $11.2M | ||
| Q1 25 | $24.3M | $9.2M | ||
| Q4 24 | $23.7M | $8.3M | ||
| Q3 24 | $25.6M | $7.3M | ||
| Q2 24 | $23.8M | $7.4M | ||
| Q1 24 | $24.5M | $6.5M |
净利润BCMLTLSI
| Q4 25 | $6.9M | $-9.8M | ||
| Q3 25 | $5.0M | $-10.8M | ||
| Q2 25 | $6.4M | $-8.3M | ||
| Q1 25 | $5.7M | $-10.4M | ||
| Q4 24 | $6.1M | $-10.1M | ||
| Q3 24 | $6.0M | $-2.4M | ||
| Q2 24 | $5.6M | $-4.3M | ||
| Q1 24 | $5.9M | $-13.2M |
毛利率BCMLTLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率BCMLTLSI
| Q4 25 | 36.6% | -24.8% | ||
| Q3 25 | 26.3% | -77.9% | ||
| Q2 25 | 35.3% | -65.4% | ||
| Q1 25 | 31.6% | -79.9% | ||
| Q4 24 | 34.2% | -91.8% | ||
| Q3 24 | 32.4% | -118.9% | ||
| Q2 24 | 31.9% | -111.0% | ||
| Q1 24 | 33.3% | -180.8% |
净利率BCMLTLSI
| Q4 25 | 26.5% | -73.9% | ||
| Q3 25 | 19.5% | -93.5% | ||
| Q2 25 | 25.8% | -73.9% | ||
| Q1 25 | 23.4% | -113.2% | ||
| Q4 24 | 25.9% | -122.4% | ||
| Q3 24 | 23.5% | -32.6% | ||
| Q2 24 | 23.6% | -58.8% | ||
| Q1 24 | 24.0% | -204.5% |
每股收益（稀释后）BCMLTLSI
| Q4 25 | $0.63 | $-0.22 | ||
| Q3 25 | $0.46 | $-0.96 | ||
| Q2 25 | $0.58 | $-0.27 | ||
| Q1 25 | $0.51 | $-0.39 | ||
| Q4 24 | $0.55 | $-0.38 | ||
| Q3 24 | $0.54 | $-0.12 | ||
| Q2 24 | $0.50 | $-0.21 | ||
| Q1 24 | $0.51 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $338.6M | $-33.9M |
| 总资产 | $2.6B | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCMLTLSI
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
股东权益BCMLTLSI
| Q4 25 | $338.6M | $-33.9M | ||
| Q3 25 | $334.3M | $-26.7M | ||
| Q2 25 | $330.6M | $-19.4M | ||
| Q1 25 | $329.3M | $-34.4M | ||
| Q4 24 | $324.4M | $-25.9M | ||
| Q3 24 | $321.7M | $-20.4M | ||
| Q2 24 | $315.3M | $-25.3M | ||
| Q1 24 | $314.2M | $-36.0M |
总资产BCMLTLSI
| Q4 25 | $2.6B | $35.3M | ||
| Q3 25 | $2.6B | $36.5M | ||
| Q2 25 | $2.6B | $41.3M | ||
| Q1 25 | $2.6B | $28.6M | ||
| Q4 24 | $2.7B | $24.0M | ||
| Q3 24 | $2.6B | $27.5M | ||
| Q2 24 | $2.6B | $32.4M | ||
| Q1 24 | $2.6B | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.8M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $30.1M | $-2.5M |
| 自由现金流率自由现金流/营收 | 116.2% | -19.1% |
| 资本支出强度资本支出/营收 | 6.7% | 0.3% |
| 现金转化率经营现金流/净利润 | 4.64× | — |
| 过去12个月自由现金流最近4个季度 | $51.1M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流BCMLTLSI
| Q4 25 | $31.8M | $-2.5M | ||
| Q3 25 | $7.3M | $-3.7M | ||
| Q2 25 | $6.4M | $-7.3M | ||
| Q1 25 | $9.3M | $-4.5M | ||
| Q4 24 | $30.4M | $-5.7M | ||
| Q3 24 | $9.6M | $-10.8M | ||
| Q2 24 | $7.7M | $-13.4M | ||
| Q1 24 | $5.1M | $-10.9M |
自由现金流BCMLTLSI
| Q4 25 | $30.1M | $-2.5M | ||
| Q3 25 | $6.2M | $-3.9M | ||
| Q2 25 | $5.6M | $-7.4M | ||
| Q1 25 | $9.1M | $-5.3M | ||
| Q4 24 | $28.7M | $-5.8M | ||
| Q3 24 | $9.4M | $-11.0M | ||
| Q2 24 | $7.4M | $-13.5M | ||
| Q1 24 | $3.9M | $-10.9M |
自由现金流率BCMLTLSI
| Q4 25 | 116.2% | -19.1% | ||
| Q3 25 | 24.3% | -33.9% | ||
| Q2 25 | 22.8% | -66.1% | ||
| Q1 25 | 37.6% | -57.3% | ||
| Q4 24 | 121.1% | -69.7% | ||
| Q3 24 | 36.6% | -149.9% | ||
| Q2 24 | 31.2% | -183.1% | ||
| Q1 24 | 16.1% | -169.3% |
资本支出强度BCMLTLSI
| Q4 25 | 6.7% | 0.3% | ||
| Q3 25 | 4.3% | 1.9% | ||
| Q2 25 | 3.0% | 0.8% | ||
| Q1 25 | 0.6% | 8.2% | ||
| Q4 24 | 7.2% | 0.6% | ||
| Q3 24 | 1.0% | 2.3% | ||
| Q2 24 | 1.0% | 0.8% | ||
| Q1 24 | 4.7% | 1.0% |
现金转化率BCMLTLSI
| Q4 25 | 4.64× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.86× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
